| Distinct Regulatory Proteins Control the Graded Transcriptional Response to Increasing H2O2 Levels in Fission Yeast Schizosaccharomyces pombe J Quinn, VJ Findlay, K Dawson, JBA Millar, N Jones, BA Morgan, ... Molecular biology of the cell 13 (3), 805-816, 2002 | 246 | 2002 |
| A 2-Cys peroxiredoxin regulates peroxide-induced oxidation and activation of a stress-activated MAP kinase EA Veal, VJ Findlay, AM Day, SM Bozonet, JM Evans, J Quinn, ... Molecular cell 15 (1), 129-139, 2004 | 240 | 2004 |
| A novel role for human sulfiredoxin in the reversal of glutathionylation VJ Findlay, DM Townsend, TE Morris, JP Fraser, L He, KD Tew Cancer research 66 (13), 6800-6806, 2006 | 223 | 2006 |
| Oxidation of a eukaryotic 2-Cys peroxiredoxin is a molecular switch controlling the transcriptional response to increasing levels of hydrogen peroxide SM Bozonet, VJ Findlay, AM Day, J Cameron, EA Veal, BA Morgan Journal of Biological Chemistry 280 (24), 23319-23327, 2005 | 184 | 2005 |
| Tumor cell responses to a novel glutathione S-transferase–activated nitric oxide-releasing prodrug VJ Findlay, DM Townsend, JE Saavedra, GS Buzard, ML Citro, LK Keefer, ... Molecular pharmacology 65 (5), 1070-1079, 2004 | 155 | 2004 |
| Glutathione S‐transferases as regulators of kinase pathways and anticancer drug targets DM Townsend, VL Findlay, KD Tew Methods in enzymology 401, 287-307, 2005 | 146 | 2005 |
| Thioredoxin peroxidase is required for the transcriptional response to oxidative stress in budding yeast SJ Ross, VJ Findlay, P Malakasi, BA Morgan Molecular biology of the cell 11 (8), 2631-2642, 2000 | 143 | 2000 |
| Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer VJ Findlay, C Wang, DK Watson, ER Camp Cancer gene therapy 21 (5), 181-187, 2014 | 130 | 2014 |
| A glutathione S-transferase π-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins DM Townsend, VJ Findlay, F Fazilev, M Ogle, J Fraser, JE Saavedra, X Ji, ... Molecular pharmacology 69 (2), 501-508, 2006 | 126 | 2006 |
| Understanding the role of ETS-mediated gene regulation in complex biological processes VJ Findlay, AC LaRue, DP Turner, PM Watson, DK Watson Advances in cancer research 119, 1-61, 2013 | 116 | 2013 |
| miR-145 antagonizes SNAI1-mediated stemness and radiation resistance in colorectal cancer Y Zhu, C Wang, SA Becker, K Hurst, LM Nogueira, VJ Findlay, ER Camp Molecular Therapy 26 (3), 744-754, 2018 | 108 | 2018 |
| PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activity JE Saavedra, A Srinivasan, GS Buzard, KM Davies, DJ Waterhouse, ... Journal of medicinal chemistry 49 (3), 1157-1164, 2006 | 103 | 2006 |
| Sulfiredoxin: a potential therapeutic agent? VJ Findlay, H Tapiero, DM Townsend Biomedicine & Pharmacotherapy 59 (7), 374-379, 2005 | 102 | 2005 |
| AGE metabolites: a biomarker linked to cancer disparity? D Foster, L Spruill, KR Walter, LM Nogueira, H Fedarovich, RY Turner, ... Cancer Epidemiology, Biomarkers & Prevention 23 (10), 2186-2191, 2014 | 77 | 2014 |
| Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression DP Turner, VJ Findlay, O Moussa, VI Semenchenko, PM Watson, ... The Prostate 71 (16), 1723-1735, 2011 | 72 | 2011 |
| MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer VJ Findlay, DP Turner, O Moussa, DK Watson Cancer research 68 (20), 8499-8506, 2008 | 71 | 2008 |
| Defining ETS transcription regulatory networks and their contribution to breast cancer progression DP Turner, VJ Findlay, O Moussa, DK Watson Journal of cellular biochemistry 102 (3), 549-559, 2007 | 67 | 2007 |
| MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer QJ Guo, JN Mills, SG Bandurraga, LM Nogueira, NJ Mason, ER Camp, ... Breast Cancer Research 15, 1-13, 2013 | 65 | 2013 |
| SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression VJ Findlay, C Wang, LM Nogueira, K Hurst, D Quirk, SP Ethier, ... Molecular cancer therapeutics 13 (11), 2713-2726, 2014 | 63 | 2014 |
| Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression DP Turner, VJ Findlay, AD Kirven, O Moussa, DK Watson Molecular biology of the cell 19 (9), 3745-3757, 2008 | 60 | 2008 |
